Puiatti P, Cervetti O, Forte M, Zina G
Drugs Exp Clin Res. 1986;12(5):405-7.
Ketoconazole is a new antifungal drug, used for oral treatment, with a broad spectrum of activity. It is a member of the imidazole series and is active in superficial and deep mycotic diseases, in candidosis and pityriasis versicolor. This new imidazole derivative has been successfully administered in several cases of dermatophytosis, yeasts and pityriasis versicolor in the authors' clinic, as well as in many other research centres. Treatment has been given to patients with tinea corporis, tinea cruris, tinea pedis, with or without location in interdigital spaces, while the cases of tinea capitis are still under investigation. The following variants of candida infections have been treated: onychomycosis, intertrigo and mucocutaneous candidosis due to prolonged immunosuppressive therapy. No remarkable haematochemical disorders have been observed after treatment.
酮康唑是一种新型抗真菌药物，用于口服治疗，具有广泛的活性谱。它是咪唑类药物的一员，对浅表和深部真菌病、念珠菌病和花斑癣均有活性。这种新型咪唑衍生物已在作者诊所的几例皮肤癣菌病、酵母菌感染和花斑癣病例中以及许多其他研究中心成功应用。已对患有体癣、股癣、足癣（无论是否累及指间间隙）的患者进行了治疗，而头癣病例仍在研究中。已对以下念珠菌感染变体进行了治疗：甲癣、擦烂和因长期免疫抑制治疗引起的黏膜皮肤念珠菌病。治疗后未观察到明显的血液生化紊乱。
